Pfizer Inc. and China’s Innovent Biologics have announced a global licensing and collaboration agreement. The deal, valued at up to $10.5 billion, is set to develop 12 early-stage cancer drugs. The ...

A study of nearly 500 domestic cats uncovered similarities between cancer gene mutations in felines and humans.

Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.

A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, ...

Learn more Pfizer and Innovent Biologics have signed a global licensing and collaboration agreement worth up to $10.5bn for the research and development of a portfolio of 12 early-stage cancer ...

A lack of sleep could be fuelling a surge in cancer among the under-50s, according to the largest study of its kind.

E-cigarettes may carry cancer risks of their own, researchers warn. A doctor explains what people who vape and parents should ...

Mercury in Cancer creates a stronger focus on emotional understanding, personal communication, thoughtful reflection, and ...

Pfizer is paying Innovent $650 million upfront to partner on cancer drug development, following Bristol Myers Squibb by ...

Pfizer and Innovent Biologics signed a licensing agreement to research and develop 12 cancer medicines. The agreement includes licensing, co-development and co-commercialization across the ...

One of the biggest advances in pancreatic cancer in decades came out of a crazy idea born in a Harvard University lab.

Our scientists are accelerating research by looking to improve anti-tumor immune response, targeting specific cancer cells and helping inhibit cancer growth.